Evidence map›Paper›PMID 40161887›Full record

ArticleADMET & DMPK2025

Microwave coprocessing of modafinil with Gelucire

Derar Omari, Assayed Sallam, Iyad Rashid, Shereen M Assaf, Faisal Al-Akayleh, Khaldoun A Al-Sou Od

Abstract read
In one paragraph

Article in ADMET & DMPK, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Derar OmariDepartment of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.
Assayed SallamTQ Pharma, Amman, Jordan.
Iyad RashidTQ Pharma, Amman, Jordan.
Shereen M AssafDepartment of Pharmaceutical Technology, Faulty of Pharmacy, Jordan University of Science and Technology, P. O. Box 3030, Irbid 22110, Jordan.
Faisal Al-AkaylehFaculty of Pharmacy and Medical Sciences, University of Petra, Amman 11196, Jordan.
Khaldoun A Al-Sou OdDepartment of Chemistry, Faculty of Science, Al Al-Bayt University, P. O. Box 130040, Mafraq, 25113, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Modafinil, a wakefulness-promoting agent, is primarily used to treat excessive daytime sleepiness associated with narcolepsy and fatigue. As a BCS class II drug, modafinil exhibits low solubility and high permeability, with its crystalline structure significantly impacting dissolution, bioavailability, and compressibility. This study explores the use of microwave energy to alter the crystalline structure of modafinil in the presence of Gelucire Methods: Modafinil was treated with microwave energy to form complexes with Gelucire Results: XRPD analysis revealed distinct crystalline patterns for microwave and hot-melt complexes compared to physical mixtures, with increased amorphousness observed through crystallinity, relative crystallinity, and relative intensity parameters. DSC thermograms indicated a reduction in melting endotherms and heat flow, suggesting structural changes due to complex formation. Compressibility and compactibility studies demonstrated optimal performance at low Gelucire Conclusions: The study demonstrates that microwave energy effectively alters the crystalline structure of modafinil in the presence of Gelucire

Indexed as

carbonyl oxygen of modafinilcrystallinitymolecular modelingTablet compressibility

Identifiers

PMID40161887
PMCPMC11954140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.